CSBR

Healthcare Biotechnology

Champions Oncology, Inc.

$4.97

-0.07 -1.39% today

Price History

Not enough data

Key Stats

Market Cap

69.18M

Avg Volume

11,116

EPS

-$0.07

52W High

$8.31

52W Low

$4.59

Div. Yield

0.0%

Valuation

Forward P/E

49.70

P/B Ratio

17.75

P/S Ratio

1.14

EV/EBITDA

189.94

EV/Revenue

1.26

Margins

Gross Margin 49.8%

Operating Margin (2.7%)

Net Margin (1.9%)

EBITDA Margin 0.7%

Growth & Returns

Revenue Growth (YoY)

8.8%

Return on Equity

(28.4%)

Return on Assets

(1.8%)

Liquidity & Leverage

Current Ratio

1.03

Quick Ratio

0.96

Debt / Equity

2.46

Total Cash

4.36M

Total Debt

10.97M

About

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.